PASG vs VRTX: Which Stock is Better?

Side-by-side comparison of Passage Bio Inc and Vertex Pharmaceuticals Inc in 2026

Comparison Updated:

PASG

Passage Bio Inc

$11.67

VRTX

Vertex Pharmaceuticals Inc

$441.20

Key Metrics Comparison

MetricPASGVRTXWinner
Market Cap$37.44M$112.22BVRTX
P/E RatioN/A28.82VRTX
EPS (TTM)$N/A$15.31VRTX
Revenue Growth0.0%0.1%VRTX
Gross Margin0.0%53.7%VRTX

Analyze PASG

Full quant analysis

Analyze VRTX

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is PASG or VRTX a better investment?

Comparing PASG and VRTX: Passage Bio Inc has a market cap of $37.44M while Vertex Pharmaceuticals Inc has $112.22B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between PASG and VRTX?

PASG (Passage Bio Inc) and VRTX (Vertex Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: PASG or VRTX?

Based on P/E ratios, compare detailed valuation metrics on our dashboard.

Which is growing faster: PASG or VRTX?

VRTX has higher revenue growth at 0.1% vs 0.0% for PASG.

Which company is more profitable: PASG or VRTX?

Vertex Pharmaceuticals Inc (VRTX) has higher gross margins at 53.7% compared to 0.0% for PASG.

Which is the larger company: PASG or VRTX?

Vertex Pharmaceuticals Inc (VRTX) is larger with a market cap of $112.22B compared to $37.44M for PASG.

Should I buy PASG or VRTX in 2026?

Both PASG and VRTX have investment merit. PASG trades at $11.67 while VRTX trades at $441.20. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between PASG and VRTX stock?

Key differences: Market Cap ($37.44M vs $112.22B), P/E Ratio (N/A vs 28.8x), Revenue Growth (0.0% vs 0.1%), Gross Margin (0.0% vs 53.7%).

Popular Stock Comparisons